Yi Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yi Li has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Chen Meng
Department of Geriatric Medicine, Beijing Hospital, National Centre for Gerontology; National Clinical Research Centre for Gerontology; The Key Laboratory of Geriatrics of NHC; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
1 shared publicationDi Guo
Department of Cardiology, Beijing Hospital, National Centre for Gerontology; National Clinical Research Centre for Gerontology; The Key Laboratory of Geriatrics of NHC; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
1 shared publicationGuobin Miao
Department Of Emergency, Emergency General Hospital, Beijing, China
1 shared publicationHaoning Ma
Department of Orthopaedics, China-Japan Friendship Hospital
1 shared publication- Hua Wang
Department of Cardiology, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
1 shared publication - Jiefu Yang
Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 31 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Multidisciplinary intervention in frail elderly patients with cardiovascular diseases: a multicentre, single-blinded, randomised controlled trial
Evidence supporting multidisciplinary interventions for frailty in elderly cardiovascular inpatients remains limited. In this completed multicentre, single-blinded, randomised controlled trial (ChiCTR1900022623), 333 frail inpatients aged ≥ 70 years with cardiovascular diseases were randomly assigned to RENAP (Rehabilitation exercises, patient Education, Nutritional guidance, Acupoint massage, and Polypharmacy management) programme ( n = 166) or usual care ( n = 167). The trial was supported by grants from the Beijing Municipal Science and Technology Commission and the Chinese Academy of Medical Sciences. The primary outcomes were changes from baseline to 12 months in Fried Frailty Phenotype (FFP) and Short Physical Performance Battery (SPPB) scores at one year. RENAP significantly improved FFP score [t(993) = −4.79; P < 0.001; adjusted mean difference −0.79; 95% CI: −1.11 to −0.46] and SPPB score [t(993) = 4.06; P < 0.001; adjusted mean difference 2.02; 95% CI: 1.04 to 2.99]. No treatment-related serious adverse events were observed during the study. These findings suggest that a hospital-initiated multidisciplinary programme may improve frailty and physical function in frail elderly adults with cardiovascular diseases. The single-city setting and loss to follow-up may limit generalisability and warrant confirmation in broader healthcare settings.
- 31 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessMultidisciplinary intervention in frail elderly patients with cardiovascular diseases: a multicentre, single-blinded, randomised controlled trial
Evidence supporting multidisciplinary interventions for frailty in elderly cardiovascular inpatients remains limited. In this completed multicentre, single-blinded, randomised controlled trial (ChiCTR1900022623), 333 frail inpatients aged ≥ 70 years with cardiovascular diseases were randomly assigned to RENAP (Rehabilitation exercises, patient Education, Nutritional guidance, Acupoint massage, and Polypharmacy management) programme ( n = 166) or usual care ( n = 167). The trial was supported by grants from the Beijing Municipal Science and Technology Commission and the Chinese Academy of Medical Sciences. The primary outcomes were changes from baseline to 12 months in Fried Frailty Phenotype (FFP) and Short Physical Performance Battery (SPPB) scores at one year. RENAP significantly improved FFP score [t(993) = −4.79; P < 0.001; adjusted mean difference −0.79; 95% CI: −1.11 to −0.46] and SPPB score [t(993) = 4.06; P < 0.001; adjusted mean difference 2.02; 95% CI: 1.04 to 2.99]. No treatment-related serious adverse events were observed during the study. These findings suggest that a hospital-initiated multidisciplinary programme may improve frailty and physical function in frail elderly adults with cardiovascular diseases. The single-city setting and loss to follow-up may limit generalisability and warrant confirmation in broader healthcare settings.
- Open Access
- 10 July 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1826823
Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis
Background: Psoriasis is a chronic inflammatory disease associated with increased risk of osteoporosis. However, practical tools for identifying high-risk patients in clinical settings remain limited. This study aimed to develop and validate a nomogram for predicting osteoporosis in patients with psoriasis. Methods: A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025. Patients were randomly divided into training ( n = 447) and validation ( n = 192) sets at a 7:3 ratio. Osteoporosis was defined as dual-energy X-ray absorptiometry (DXA) T -score ≤−2.5. Univariate analysis and multivariate logistic regression were performed to identify independent risk factors. A nomogram was constructed based on the final model and evaluated using C-index, calibration curves, and decision curve analysis (DCA). Results: The overall prevalence of osteoporosis was 11.7% (75/639). Six independent risk factors were identified: advanced age (OR = 4.054, 95%CI 2.281–7.237), disease duration (OR = 1.068, 95%CI 1.026–1.11), psoriatic arthritis (OR = 2.178, 95%CI 1.243–3.796), vitamin D deficiency (OR = 5.148, 95%CI 1.986–17.672), systemic corticosteroid use (OR = 3.501, 95%CI 1.756–6.826), male sex (OR = 0.399, 95%CI 0.229–0.686). The nomogram demonstrated good discrimination with AUC of 0.824 in the training set and 0.771 in the validation set. Calibration curves showed excellent agreement between predicted and observed probabilities. DCA confirmed the clinical utility of the model. Conclusion: We developed and validated a practical nomogram incorporating psoriasis-specific and traditional risk factors for predicting osteoporosis risk. This tool may facilitate early identification of high-risk patients and guide clinical decision-making for DXA screening and preventive interventions.
- 10 July 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1826823
Open AccessDevelopment and validation of a predictive nomogram for osteoporosis in patients with psoriasis
Background: Psoriasis is a chronic inflammatory disease associated with increased risk of osteoporosis. However, practical tools for identifying high-risk patients in clinical settings remain limited. This study aimed to develop and validate a nomogram for predicting osteoporosis in patients with psoriasis. Methods: A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025. Patients were randomly divided into training ( n = 447) and validation ( n = 192) sets at a 7:3 ratio. Osteoporosis was defined as dual-energy X-ray absorptiometry (DXA) T -score ≤−2.5. Univariate analysis and multivariate logistic regression were performed to identify independent risk factors. A nomogram was constructed based on the final model and evaluated using C-index, calibration curves, and decision curve analysis (DCA). Results: The overall prevalence of osteoporosis was 11.7% (75/639). Six independent risk factors were identified: advanced age (OR = 4.054, 95%CI 2.281–7.237), disease duration (OR = 1.068, 95%CI 1.026–1.11), psoriatic arthritis (OR = 2.178, 95%CI 1.243–3.796), vitamin D deficiency (OR = 5.148, 95%CI 1.986–17.672), systemic corticosteroid use (OR = 3.501, 95%CI 1.756–6.826), male sex (OR = 0.399, 95%CI 0.229–0.686). The nomogram demonstrated good discrimination with AUC of 0.824 in the training set and 0.771 in the validation set. Calibration curves showed excellent agreement between predicted and observed probabilities. DCA confirmed the clinical utility of the model. Conclusion: We developed and validated a practical nomogram incorporating psoriasis-specific and traditional risk factors for predicting osteoporosis risk. This tool may facilitate early identification of high-risk patients and guide clinical decision-making for DXA screening and preventive interventions.